Skip to content
PICO Portalanswers from OpenAlex

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

PaperCitations, authors & open-access status

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma is a paper indexed in PICO Portal from OpenAlex.

How many citations does Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma have?

PICO Portalcitation count

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma has 864 citations in the OpenAlex counts PICO Portal stores.

When was Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma published?

PICO Portalyear

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma has 2010 year in the PICO Portal index.

What is the open-access status of Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma?

PICO Portaloa status

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma has green oa status in the PICO Portal index.

What is the DOI of Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma?

PICO Portaldoi

The DOI for Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma is on the source record.

What is the PMID of Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma?

PICO Portalpmid

The PMID for Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma is on the source record.

What is the OpenAlex record for Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma?

PICO Portalopenalex

The OpenAlex for Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial